Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial
Prospective, Multicenter, Randomized Controlled Trial of Endovascular Aneurysm Repair Using a Bilateral Percutaneous Approach (PEVAR) vs. Standard Approach (SEVAR) Using the IntuiTrak Endovascular AAA Delivery System and the Prostar XL or Perclose ProGlide Suture-Mediated Closure System
Status: Enrolling
Updated:  1/27/2014
University of Virginia
2283
mi
from 98109
Charlottesville, VA
Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial
Prospective, Multicenter, Randomized Controlled Trial of Endovascular Aneurysm Repair Using a Bilateral Percutaneous Approach (PEVAR) vs. Standard Approach (SEVAR) Using the IntuiTrak Endovascular AAA Delivery System and the Prostar XL or Perclose ProGlide Suture-Mediated Closure System
Status: Enrolling
Updated: 1/27/2014
University of Virginia
2283
mi
from 98109
Charlottesville, VA
Click here to add this to my saved trials
Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial
Prospective, Multicenter, Randomized Controlled Trial of Endovascular Aneurysm Repair Using a Bilateral Percutaneous Approach (PEVAR) vs. Standard Approach (SEVAR) Using the IntuiTrak Endovascular AAA Delivery System and the Prostar XL or Perclose ProGlide Suture-Mediated Closure System
Status: Enrolling
Updated:  1/27/2014
Inova Fairfax
2316
mi
from 98109
Falls Church, VA
Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial
Prospective, Multicenter, Randomized Controlled Trial of Endovascular Aneurysm Repair Using a Bilateral Percutaneous Approach (PEVAR) vs. Standard Approach (SEVAR) Using the IntuiTrak Endovascular AAA Delivery System and the Prostar XL or Perclose ProGlide Suture-Mediated Closure System
Status: Enrolling
Updated: 1/27/2014
Inova Fairfax
2316
mi
from 98109
Falls Church, VA
Click here to add this to my saved trials
Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial
Prospective, Multicenter, Randomized Controlled Trial of Endovascular Aneurysm Repair Using a Bilateral Percutaneous Approach (PEVAR) vs. Standard Approach (SEVAR) Using the IntuiTrak Endovascular AAA Delivery System and the Prostar XL or Perclose ProGlide Suture-Mediated Closure System
Status: Enrolling
Updated:  1/27/2014
University of Wisconsin
1616
mi
from 98109
Madison, WI
Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial
Prospective, Multicenter, Randomized Controlled Trial of Endovascular Aneurysm Repair Using a Bilateral Percutaneous Approach (PEVAR) vs. Standard Approach (SEVAR) Using the IntuiTrak Endovascular AAA Delivery System and the Prostar XL or Perclose ProGlide Suture-Mediated Closure System
Status: Enrolling
Updated: 1/27/2014
University of Wisconsin
1616
mi
from 98109
Madison, WI
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure
A Phase I/II Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Retrograde Delivery to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  2/6/2014
Cardiology PC
2078
mi
from 98109
Birmingham, AL
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure
A Phase I/II Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Retrograde Delivery to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 2/6/2014
Cardiology PC
2078
mi
from 98109
Birmingham, AL
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure
A Phase I/II Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Retrograde Delivery to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  2/6/2014
University of Florida
2452
mi
from 98109
Gainsville, FL
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure
A Phase I/II Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Retrograde Delivery to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 2/6/2014
University of Florida
2452
mi
from 98109
Gainsville, FL
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure
A Phase I/II Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Retrograde Delivery to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  2/6/2014
The Carl and Edyth Lindner Center for Research and Education at the Christ Hospital
1967
mi
from 98109
Cincinnati, OH
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure
A Phase I/II Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Retrograde Delivery to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 2/6/2014
The Carl and Edyth Lindner Center for Research and Education at the Christ Hospital
1967
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure
A Phase I/II Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Retrograde Delivery to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated:  2/6/2014
University of Utah
703
mi
from 98109
Salt Lake City, UT
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure
A Phase I/II Study to Evaluate the Safety and Efficacy of JVS-100 Administered by Retrograde Delivery to Cohorts of Adults With Ischemic Heart Failure
Status: Enrolling
Updated: 2/6/2014
University of Utah
703
mi
from 98109
Salt Lake City, UT
Click here to add this to my saved trials
Developing a "Hub and Satellite" Heart Failure Provider's Network: A New Model of Community Based Outpatient Clinic (CBOC) Providers Study
Developing a Hub and Satellite Heart Failure Providers Network
Status: Enrolling
Updated:  2/6/2014
Tennessee Valley Healthcare System Nashville Campus, Nashville, TN
1971
mi
from 98109
Nashville, TN
Developing a "Hub and Satellite" Heart Failure Provider's Network: A New Model of Community Based Outpatient Clinic (CBOC) Providers Study
Developing a Hub and Satellite Heart Failure Providers Network
Status: Enrolling
Updated: 2/6/2014
Tennessee Valley Healthcare System Nashville Campus, Nashville, TN
1971
mi
from 98109
Nashville, TN
Click here to add this to my saved trials
SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy
Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy (SAPPHIRE Worldwide)
Status: Enrolling
Updated:  2/7/2014
Christiana Care Health Services, Inc
2357
mi
from 98109
Newark, DE
SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy
Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy (SAPPHIRE Worldwide)
Status: Enrolling
Updated: 2/7/2014
Christiana Care Health Services, Inc
2357
mi
from 98109
Newark, DE
Click here to add this to my saved trials
SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy
Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy (SAPPHIRE Worldwide)
Status: Enrolling
Updated:  2/7/2014
Iowa Clinic, Heart & Vascular Care
1456
mi
from 98109
West Des Moines, IA
SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy
Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy (SAPPHIRE Worldwide)
Status: Enrolling
Updated: 2/7/2014
Iowa Clinic, Heart & Vascular Care
1456
mi
from 98109
West Des Moines, IA
Click here to add this to my saved trials
SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy
Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy (SAPPHIRE Worldwide)
Status: Enrolling
Updated:  2/7/2014
Bryan LGH Heart Institute
1350
mi
from 98109
Lincoln, NE
SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy
Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy (SAPPHIRE Worldwide)
Status: Enrolling
Updated: 2/7/2014
Bryan LGH Heart Institute
1350
mi
from 98109
Lincoln, NE
Click here to add this to my saved trials
SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy
Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy (SAPPHIRE Worldwide)
Status: Enrolling
Updated:  2/7/2014
Harrisburg Hospital
2282
mi
from 98109
Harrisburg, PA
SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy
Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy (SAPPHIRE Worldwide)
Status: Enrolling
Updated: 2/7/2014
Harrisburg Hospital
2282
mi
from 98109
Harrisburg, PA
Click here to add this to my saved trials
SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy
Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy (SAPPHIRE Worldwide)
Status: Enrolling
Updated:  2/7/2014
The Heart Center, PC
2151
mi
from 98109
Kingsport, TN
SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy
Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy (SAPPHIRE Worldwide)
Status: Enrolling
Updated: 2/7/2014
The Heart Center, PC
2151
mi
from 98109
Kingsport, TN
Click here to add this to my saved trials
Activation Timing and Atrial Fibrillation
Proof-of-concept Study to Assess Ventricular Activation Timing During Atrial Fibrillation, or Bundle Branch Block and Sinus Rhythm
Status: Enrolling
Updated:  2/12/2014
St. Mary's Medical Center
mi
from 98109
Duluth, MN
Activation Timing and Atrial Fibrillation
Proof-of-concept Study to Assess Ventricular Activation Timing During Atrial Fibrillation, or Bundle Branch Block and Sinus Rhythm
Status: Enrolling
Updated: 2/12/2014
St. Mary's Medical Center
mi
from 98109
Duluth, MN
Click here to add this to my saved trials
Impact of Ticagrelor Re-load on Pharmacodynamic Profiles
Impact of Ticagrelor Re-load on Pharmacodynamic Profiles in Patients on Maintenance Ticagrelor Therapy
Status: Enrolling
Updated:  2/14/2014
University of Florida
2461
mi
from 98109
Jacksonville, FL
Impact of Ticagrelor Re-load on Pharmacodynamic Profiles
Impact of Ticagrelor Re-load on Pharmacodynamic Profiles in Patients on Maintenance Ticagrelor Therapy
Status: Enrolling
Updated: 2/14/2014
University of Florida
2461
mi
from 98109
Jacksonville, FL
Click here to add this to my saved trials
Phosphorous Magnetic Resonance Spectroscopy of Heart
31P Magnetic Resonance Spectroscopy of Heart
Status: Enrolling
Updated:  2/18/2014
Washington University, St. Louis
1716
mi
from 98109
St. Louis, MO
Phosphorous Magnetic Resonance Spectroscopy of Heart
31P Magnetic Resonance Spectroscopy of Heart
Status: Enrolling
Updated: 2/18/2014
Washington University, St. Louis
1716
mi
from 98109
St. Louis, MO
Click here to add this to my saved trials
Phosphorous Magnetic Resonance Spectroscopy of Heart
31P Magnetic Resonance Spectroscopy of Heart
Status: Enrolling
Updated:  2/18/2014
Washington University, St. Louis
1716
mi
from 98109
St. Louis, MO
Phosphorous Magnetic Resonance Spectroscopy of Heart
31P Magnetic Resonance Spectroscopy of Heart
Status: Enrolling
Updated: 2/18/2014
Washington University, St. Louis
1716
mi
from 98109
St. Louis, MO
Click here to add this to my saved trials
Effects of Epicatechin on Functional Capacity, Skeletal Muscle Structure and Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction (HFPEF)
Status: Enrolling
Updated:  2/19/2014
The University of California, San Diego
1056
mi
from 98109
La Jolla, CA
Effects of Epicatechin on Functional Capacity, Skeletal Muscle Structure and Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction (HFPEF)
Status: Enrolling
Updated: 2/19/2014
The University of California, San Diego
1056
mi
from 98109
La Jolla, CA
Click here to add this to my saved trials
Evaluation of Cross-Linked Polyelectrolyte (CLP) With Placebo in Heart Failure Subjects
A Phase 2b, Randomized, Double-Blind, Multi-center Study Comparing Cross-linked Polyelectrolyte (CLP) With Placebo in Heart Failure Subjects
Status: Enrolling
Updated:  3/3/2014
Orange Country Research Center
988
mi
from 98109
Tustin, CA
Evaluation of Cross-Linked Polyelectrolyte (CLP) With Placebo in Heart Failure Subjects
A Phase 2b, Randomized, Double-Blind, Multi-center Study Comparing Cross-linked Polyelectrolyte (CLP) With Placebo in Heart Failure Subjects
Status: Enrolling
Updated: 3/3/2014
Orange Country Research Center
988
mi
from 98109
Tustin, CA
Click here to add this to my saved trials
Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care
Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care
Status: Enrolling
Updated:  3/4/2014
Brigham and Women's Hosp
2485
mi
from 98109
Boston, MA
Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care
Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care
Status: Enrolling
Updated: 3/4/2014
Brigham and Women's Hosp
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Pharmacokinetics of Dexmedetomidine in Children During Cardiopulmonary Bypass (CPB)
Pharmacokinetics of Dexmedetomidine in Children During Cardiopulmonary Bypass (CPB)
Status: Enrolling
Updated:  3/6/2014
Duke University Hospital
2338
mi
from 98109
Durham, NC
Pharmacokinetics of Dexmedetomidine in Children During Cardiopulmonary Bypass (CPB)
Pharmacokinetics of Dexmedetomidine in Children During Cardiopulmonary Bypass (CPB)
Status: Enrolling
Updated: 3/6/2014
Duke University Hospital
2338
mi
from 98109
Durham, NC
Click here to add this to my saved trials
Aspirin and Plavix Following Coronary Artery Bypass Grafting
Aspirin and Plavix Following Coronary Artery Bypass Grafting (ASAP-CABG)
Status: Enrolling
Updated:  3/7/2014
Brooke Army Medical Center
1787
mi
from 98109
San Antonio, TX
Aspirin and Plavix Following Coronary Artery Bypass Grafting
Aspirin and Plavix Following Coronary Artery Bypass Grafting (ASAP-CABG)
Status: Enrolling
Updated: 3/7/2014
Brooke Army Medical Center
1787
mi
from 98109
San Antonio, TX
Click here to add this to my saved trials
Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF Therapy
Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF Therapy
Status: Enrolling
Updated:  3/13/2014
Vitreo-Retinal Associates, PC
2454
mi
from 98109
Worcester, MA
Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF Therapy
Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF Therapy
Status: Enrolling
Updated: 3/13/2014
Vitreo-Retinal Associates, PC
2454
mi
from 98109
Worcester, MA
Click here to add this to my saved trials
Laser Therapy Versus Electrosurgery For Nasal Telangiectasias
Evaluation of Laser Therapy Vs Electrosurgery For Nasal Telangiectasias Using A Novel Vascular Imaging Device
Status: Enrolling
Updated:  3/14/2014
University of California, Davis Department of Dermatology
627
mi
from 98109
Sacramento, CA
Laser Therapy Versus Electrosurgery For Nasal Telangiectasias
Evaluation of Laser Therapy Vs Electrosurgery For Nasal Telangiectasias Using A Novel Vascular Imaging Device
Status: Enrolling
Updated: 3/14/2014
University of California, Davis Department of Dermatology
627
mi
from 98109
Sacramento, CA
Click here to add this to my saved trials
A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus
A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus
Status: Enrolling
Updated:  3/19/2014
Retinal Consultants of Arizona
1112
mi
from 98109
Phoenix, AZ
A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus
A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus
Status: Enrolling
Updated: 3/19/2014
Retinal Consultants of Arizona
1112
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
Adipose Derived Regenerative Cellular Therapy of Chronic Wounds
Adipose Derived Regenerative Cellular Therapy of Chronic Wounds
Status: Enrolling
Updated:  3/19/2014
Tower Outpatient Surgical Center
962
mi
from 98109
Los Angeles, CA
Adipose Derived Regenerative Cellular Therapy of Chronic Wounds
Adipose Derived Regenerative Cellular Therapy of Chronic Wounds
Status: Enrolling
Updated: 3/19/2014
Tower Outpatient Surgical Center
962
mi
from 98109
Los Angeles, CA
Click here to add this to my saved trials
Clinical Performance Evaluation of AQT90 FLEX BNP and NT-proBNP
Clinical Sensitivity and Specificity Study of AQT90 FLEX BNP and NT-proBNP
Status: Enrolling
Updated:  3/21/2014
Wake Forest University
2274
mi
from 98109
Winston-Salem, NC
Clinical Performance Evaluation of AQT90 FLEX BNP and NT-proBNP
Clinical Sensitivity and Specificity Study of AQT90 FLEX BNP and NT-proBNP
Status: Enrolling
Updated: 3/21/2014
Wake Forest University
2274
mi
from 98109
Winston-Salem, NC
Click here to add this to my saved trials
Verizon Wireless - Sarasota Memorial Hospital Converged Health Management (CHM) For Heart Failure
Verizon Wireless - Sarasota Memorial Hospital Converged Health Management (CHM) For Heart Failure
Status: Enrolling
Updated:  3/31/2014
Sarasota Memorial Hospital Heart Failure Clinic
2553
mi
from 98109
Sarasota, FL
Verizon Wireless - Sarasota Memorial Hospital Converged Health Management (CHM) For Heart Failure
Verizon Wireless - Sarasota Memorial Hospital Converged Health Management (CHM) For Heart Failure
Status: Enrolling
Updated: 3/31/2014
Sarasota Memorial Hospital Heart Failure Clinic
2553
mi
from 98109
Sarasota, FL
Click here to add this to my saved trials
Effect of Prasugrel Versus Clopidogrel on Platelet Function After Bivalirudin Cessation
The Effect of Prasugrel as Compared to Clopidogrel on Platelet Function Immediately Following the Termination of Intravenous Bivalirudin in Patients Undergoing Percutaneous Coronary and Structural Cardiac Intervention
Status: Enrolling
Updated:  4/2/2014
Tufts Medical Center
2485
mi
from 98109
Boston, MA
Effect of Prasugrel Versus Clopidogrel on Platelet Function After Bivalirudin Cessation
The Effect of Prasugrel as Compared to Clopidogrel on Platelet Function Immediately Following the Termination of Intravenous Bivalirudin in Patients Undergoing Percutaneous Coronary and Structural Cardiac Intervention
Status: Enrolling
Updated: 4/2/2014
Tufts Medical Center
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Gas Exchange for Predicting Hospital Heart Failure Readmissions
Gas Exchange for Predicting Hospital Heart Failure Readmissions Clinical Evaluation Study
Status: Enrolling
Updated:  4/3/2014
Veterans Affairs-Washington DC
2322
mi
from 98109
Washington,
Gas Exchange for Predicting Hospital Heart Failure Readmissions
Gas Exchange for Predicting Hospital Heart Failure Readmissions Clinical Evaluation Study
Status: Enrolling
Updated: 4/3/2014
Veterans Affairs-Washington DC
2322
mi
from 98109
Washington,
Click here to add this to my saved trials
Gas Exchange for Predicting Hospital Heart Failure Readmissions
Gas Exchange for Predicting Hospital Heart Failure Readmissions Clinical Evaluation Study
Status: Enrolling
Updated:  4/3/2014
Christie Clinic
1759
mi
from 98109
Champaign, IL
Gas Exchange for Predicting Hospital Heart Failure Readmissions
Gas Exchange for Predicting Hospital Heart Failure Readmissions Clinical Evaluation Study
Status: Enrolling
Updated: 4/3/2014
Christie Clinic
1759
mi
from 98109
Champaign, IL
Click here to add this to my saved trials
Gas Exchange for Predicting Hospital Heart Failure Readmissions
Gas Exchange for Predicting Hospital Heart Failure Readmissions Clinical Evaluation Study
Status: Enrolling
Updated:  4/3/2014
Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
Gas Exchange for Predicting Hospital Heart Failure Readmissions
Gas Exchange for Predicting Hospital Heart Failure Readmissions Clinical Evaluation Study
Status: Enrolling
Updated: 4/3/2014
Massachusetts General Hospital
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
Gas Exchange for Predicting Hospital Heart Failure Readmissions
Gas Exchange for Predicting Hospital Heart Failure Readmissions Clinical Evaluation Study
Status: Enrolling
Updated:  4/3/2014
Fairview Southdale
1390
mi
from 98109
Edina, MN
Gas Exchange for Predicting Hospital Heart Failure Readmissions
Gas Exchange for Predicting Hospital Heart Failure Readmissions Clinical Evaluation Study
Status: Enrolling
Updated: 4/3/2014
Fairview Southdale
1390
mi
from 98109
Edina, MN
Click here to add this to my saved trials
Gas Exchange for Predicting Hospital Heart Failure Readmissions
Gas Exchange for Predicting Hospital Heart Failure Readmissions Clinical Evaluation Study
Status: Enrolling
Updated:  4/3/2014
Univ of Minnesota
1393
mi
from 98109
Minneapolis, MN
Gas Exchange for Predicting Hospital Heart Failure Readmissions
Gas Exchange for Predicting Hospital Heart Failure Readmissions Clinical Evaluation Study
Status: Enrolling
Updated: 4/3/2014
Univ of Minnesota
1393
mi
from 98109
Minneapolis, MN
Click here to add this to my saved trials
Gas Exchange for Predicting Hospital Heart Failure Readmissions
Gas Exchange for Predicting Hospital Heart Failure Readmissions Clinical Evaluation Study
Status: Enrolling
Updated:  4/3/2014
Washington University of Medicine
1718
mi
from 98109
St. Louis, MO
Gas Exchange for Predicting Hospital Heart Failure Readmissions
Gas Exchange for Predicting Hospital Heart Failure Readmissions Clinical Evaluation Study
Status: Enrolling
Updated: 4/3/2014
Washington University of Medicine
1718
mi
from 98109
St. Louis, MO
Click here to add this to my saved trials
Gas Exchange for Predicting Hospital Heart Failure Readmissions
Gas Exchange for Predicting Hospital Heart Failure Readmissions Clinical Evaluation Study
Status: Enrolling
Updated:  4/3/2014
Cleveland Clinic
2024
mi
from 98109
Cleveland, OH
Gas Exchange for Predicting Hospital Heart Failure Readmissions
Gas Exchange for Predicting Hospital Heart Failure Readmissions Clinical Evaluation Study
Status: Enrolling
Updated: 4/3/2014
Cleveland Clinic
2024
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
Race Difference Moxifloxacin-induced QT Prolongation Between Healthy Chinese and Caucasian Volunteers
A Double-center, Randomized, Double-blinded, 2-way Crossover, Placebo-controlled Study: Comparison of Single Oral Dose 400mg Moxifloxacin-induced QT Prolongation Between Healthy Chinese Volunteers and Caucasian Volunteers
Status: Enrolling
Updated:  4/17/2014
Spaulding Clinical Research, LLC
1665
mi
from 98109
West Bend, WI
Race Difference Moxifloxacin-induced QT Prolongation Between Healthy Chinese and Caucasian Volunteers
A Double-center, Randomized, Double-blinded, 2-way Crossover, Placebo-controlled Study: Comparison of Single Oral Dose 400mg Moxifloxacin-induced QT Prolongation Between Healthy Chinese Volunteers and Caucasian Volunteers
Status: Enrolling
Updated: 4/17/2014
Spaulding Clinical Research, LLC
1665
mi
from 98109
West Bend, WI
Click here to add this to my saved trials
Study to Improve Long Term Vein Graft Patency After Coronary Bypass Surgery by Using a Novel Endoscopic Harvesting Technique
OPTION Trial: Optimal Improvement of Vein Graft Patency Long Term by the Implementation Of Novel Endoscopic Harvesting Techniques
Status: Enrolling
Updated:  4/21/2014
Medical City Hospital
1681
mi
from 98109
Dallas, TX
Study to Improve Long Term Vein Graft Patency After Coronary Bypass Surgery by Using a Novel Endoscopic Harvesting Technique
OPTION Trial: Optimal Improvement of Vein Graft Patency Long Term by the Implementation Of Novel Endoscopic Harvesting Techniques
Status: Enrolling
Updated: 4/21/2014
Medical City Hospital
1681
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
Study to Improve Long Term Vein Graft Patency After Coronary Bypass Surgery by Using a Novel Endoscopic Harvesting Technique
OPTION Trial: Optimal Improvement of Vein Graft Patency Long Term by the Implementation Of Novel Endoscopic Harvesting Techniques
Status: Enrolling
Updated:  4/21/2014
The Heart Hospital Baylor Plano
1668
mi
from 98109
Plano, TX
Study to Improve Long Term Vein Graft Patency After Coronary Bypass Surgery by Using a Novel Endoscopic Harvesting Technique
OPTION Trial: Optimal Improvement of Vein Graft Patency Long Term by the Implementation Of Novel Endoscopic Harvesting Techniques
Status: Enrolling
Updated: 4/21/2014
The Heart Hospital Baylor Plano
1668
mi
from 98109
Plano, TX
Click here to add this to my saved trials
Frequent Dosing Regimen of Lucentis for Subjects With Persistent Diabetic Macular Edema Despite Standard antiVEGF Dosing
Frequent Dosing Regimen of Lucentis for Subjects With Persistent Diabetic Macular Edema Despite Standard AntiVEGF Dosing
Status: Enrolling
Updated:  4/30/2014
Raj K. Maturi, MD
1862
mi
from 98109
Indianapolis, IN
Frequent Dosing Regimen of Lucentis for Subjects With Persistent Diabetic Macular Edema Despite Standard antiVEGF Dosing
Frequent Dosing Regimen of Lucentis for Subjects With Persistent Diabetic Macular Edema Despite Standard AntiVEGF Dosing
Status: Enrolling
Updated: 4/30/2014
Raj K. Maturi, MD
1862
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
Measurement of D-Dimer Levels in Patients With Confirmed Deep Vein Thrombosis
Measurement of D-Dimer Levels in Patients With Confirmed Deep Vein Thrombosis
Status: Enrolling
Updated:  5/19/2014
University of Oklahoma Health Sciences Center
1524
mi
from 98109
Oklahoma City, OK
Measurement of D-Dimer Levels in Patients With Confirmed Deep Vein Thrombosis
Measurement of D-Dimer Levels in Patients With Confirmed Deep Vein Thrombosis
Status: Enrolling
Updated: 5/19/2014
University of Oklahoma Health Sciences Center
1524
mi
from 98109
Oklahoma City, OK
Click here to add this to my saved trials
Study of High Dose Vitamin C On Outcome in Cardiac Surgery Patients
Double-Blind, Randomized Study of High Dose Vitamin C On Outcome in Cardiac Surgery Patients
Status: Enrolling
Updated:  5/20/2014
Robert Wood Johnson University Hospital
2388
mi
from 98109
New Brunswick, NJ
Study of High Dose Vitamin C On Outcome in Cardiac Surgery Patients
Double-Blind, Randomized Study of High Dose Vitamin C On Outcome in Cardiac Surgery Patients
Status: Enrolling
Updated: 5/20/2014
Robert Wood Johnson University Hospital
2388
mi
from 98109
New Brunswick, NJ
Click here to add this to my saved trials
High Intensity Interval Exercise in Diastolic Heart Failure
High-intensity Aerobic Interval Training vs. Moderate-intensity Continuous Exercise Training in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated:  5/27/2014
Arizona State University
1116
mi
from 98109
Phoenix, AZ
High Intensity Interval Exercise in Diastolic Heart Failure
High-intensity Aerobic Interval Training vs. Moderate-intensity Continuous Exercise Training in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 5/27/2014
Arizona State University
1116
mi
from 98109
Phoenix, AZ
Click here to add this to my saved trials
High Intensity Interval Exercise in Diastolic Heart Failure
High-intensity Aerobic Interval Training vs. Moderate-intensity Continuous Exercise Training in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated:  5/27/2014
Mayo Clinic
1114
mi
from 98109
Scottsdale, AZ
High Intensity Interval Exercise in Diastolic Heart Failure
High-intensity Aerobic Interval Training vs. Moderate-intensity Continuous Exercise Training in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 5/27/2014
Mayo Clinic
1114
mi
from 98109
Scottsdale, AZ
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
University of Arizona Medical Center
1220
mi
from 98109
Tucson, AZ
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
University of Arizona Medical Center
1220
mi
from 98109
Tucson, AZ
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
Stanford Univ Med Ctr
704
mi
from 98109
Stanford, CA
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Stanford Univ Med Ctr
704
mi
from 98109
Stanford, CA
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
Yale University School of Medicine
2432
mi
from 98109
New Haven, CT
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Yale University School of Medicine
2432
mi
from 98109
New Haven, CT
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
University of Florida - Jacksonville
2449
mi
from 98109
Jacksonville, FL
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
University of Florida - Jacksonville
2449
mi
from 98109
Jacksonville, FL
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
Northwestern Memorial Hospital
1732
mi
from 98109
Chicago, IL
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
Northwestern Memorial Hospital
1732
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated:  6/3/2014
University of Louisville Hospital
1939
mi
from 98109
Louisville, KY
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
A Randomized, Multi-center, Prospective, Double Blind, Two-stage, Adaptive Phase II Trial of RP- 1127 (Glyburide for Injection) in Patients With a Severe Anterior Circulation Ischemic Stroke Who Are Likely to Develop Malignant Edema
Status: Enrolling
Updated: 6/3/2014
University of Louisville Hospital
1939
mi
from 98109
Louisville, KY
Click here to add this to my saved trials